Related Experiment Videos
[Microglia--new target cells for neurological therapy]
1Institutionen för neurovetenskap, Uppsala biomedicinska centrum, Uppsala universitet. Hakan.Aldskogius@neuro.uu.se
Lakartidningen
|October 4, 2000
Summary
Microglia activation in the central nervous system can harm healthy neurons. Regulating microglial activity offers a promising therapeutic strategy for neurological disorders like Alzheimer's disease.
Area of Science:
- Neuroscience
- Immunology
- Cell Biology
Context:
- Central nervous system (CNS) homeostasis is disrupted by pathological processes.
- Microglia, the resident immune cells of the CNS, become activated in response to disturbances.
- This microglial activation can lead to the release of molecules that negatively affect nearby healthy neurons.
Purpose:
- To explore the dual role of microglial activation in CNS disorders.
- To highlight the potential of modulating microglial activity for therapeutic benefit.
Summary:
- Microglial activation, a localized response to CNS disturbances, aims to contain pathology.
- However, activated microglia also release factors that can damage adjacent healthy neural tissue.
- This phenomenon is observed in conditions such as ischemia, multiple sclerosis, and Alzheimer's disease.
Impact:
- Understanding microglial behavior is crucial for developing treatments for neurodegenerative and neurological diseases.
- Targeting microglial activity presents a potential therapeutic avenue for a range of CNS disorders.
- Pharmacological interventions aimed at regulating microglial function could offer neuroprotective benefits.